{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T09:22:46Z","timestamp":1784971366295,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR\u20102011\u201002350438"],"award-info":[{"award-number":["GR\u20102011\u201002350438"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12967-019-1770-1","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T06:37:54Z","timestamp":1546929474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells"],"prefix":"10.1186","volume":"17","author":[{"given":"Valentina","family":"Masola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Granata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Signorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Bellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Violi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Onisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gambaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-6196","authenticated-orcid":false,"given":"Gianluigi","family":"Zaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"issue":"6","key":"1770_CR1","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial\u2013mesenchymal transition. J Clin Invest. 2009;119(6):1420\u20138.","journal-title":"J Clin Invest."},{"issue":"12","key":"1770_CR2","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri R, Neilson EG. Epithelial\u2013mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112(12):1776\u201384.","journal-title":"J Clin Invest."},{"issue":"1","key":"1770_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.ASN.0000106015.29070.E7","volume":"15","author":"Y Liu","year":"2004","unstructured":"Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol. 2004;15(1):1\u201312.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1770_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","volume":"7","author":"JP Thiery","year":"2006","unstructured":"Thiery JP, Sleeman JP. Complex networks orchestrate epithelial\u2013mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7(2):131\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"1770_CR5","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.bbadis.2012.09.014","volume":"1832","author":"LA Borthwick","year":"2013","unstructured":"Borthwick LA, Wynn TA, Fisher AJ. Cytokine mediated tissue fibrosis. Biochim Biophys Acta. 2013;1832(7):1049\u201360.","journal-title":"Biochim Biophys Acta"},{"key":"1770_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/B978-0-12-394305-7.00004-5","volume":"294","author":"K Lee","year":"2012","unstructured":"Lee K, Nelson CM. New insights into the regulation of epithelial\u2013mesenchymal transition and tissue fibrosis. Int Rev Cell Mol Biol. 2012;294:171\u2013221.","journal-title":"Int Rev Cell Mol Biol."},{"issue":"8","key":"1770_CR7","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood.V77.8.1627.1627","volume":"77","author":"CA Dinarello","year":"1991","unstructured":"Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood. 1991;77(8):1627\u201352.","journal-title":"Blood"},{"issue":"6","key":"1770_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.smim.2013.10.007","volume":"25","author":"P Piccioli","year":"2013","unstructured":"Piccioli P, Rubartelli A. The secretion of IL-1\u03b2 and options for release. Semin Immunol. 2013;25(6):425\u20139.","journal-title":"Semin Immunol"},{"issue":"7","key":"1770_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.imbio.2008.11.007","volume":"214","author":"C Eder","year":"2009","unstructured":"Eder C. Mechanisms of interleukin-1beta release. Immunobiology. 2009;214(7):543\u201353.","journal-title":"Immunobiology"},{"key":"1770_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.immuni.2006.02.004","volume":"24","author":"FS Sutterwala","year":"2006","unstructured":"Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, Bertin J, Coyle AJ, Gal\u00e1n JE, Askenase PW, Flavell RA. Critical role for NALP3\/CIAS1\/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity. 2006;24:317\u201327.","journal-title":"Immunity"},{"issue":"2","key":"1770_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10(2):417\u201326.","journal-title":"Mol Cell"},{"issue":"6","key":"1770_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","volume":"42","author":"IS Afonina","year":"2015","unstructured":"Afonina IS, M\u00fcller C, Martin SJ, Beyaert R. Proteolytic processing of interleukin-1 family cytokines: variations on a common theme. Immunity. 2015;42(6):991\u20131004.","journal-title":"Immunity"},{"issue":"12","key":"1770_CR13","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1002\/art.25006","volume":"60","author":"LA Joosten","year":"2009","unstructured":"Joosten LA, Netea MG, Fantuzzi G, Koenders MI, Helsen MM, Sparrer H, Pham CT, van der Meer JW, Dinarello CA, van den Berg WB. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum. 2009;60(12):3651\u201362.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1770_CR14","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0272-6386(01)80132-3","volume":"37","author":"JM Fan","year":"2001","unstructured":"Fan JM, Huang XR, Ng YY, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis. 2001;37(4):820\u201331.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1770_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1046\/j.1523-1755.2002.00401.x","volume":"62","author":"DA Vesey","year":"2002","unstructured":"Vesey DA, Cheung CW, Cuttle L, Endre ZA, Gob\u00e9 G, Johnson DW. Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production. Kidney Int. 2002;62(1):31\u201340.","journal-title":"Kidney Int"},{"issue":"3","key":"1770_CR16","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/ki.1995.126","volume":"47","author":"G Lonnemann","year":"1995","unstructured":"Lonnemann G, Shapiro L, Engler-Blum G, M\u00fcller GA, Koch KM, Dinarello CA. Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts. Kidney Int. 1995;47(3):837\u201344.","journal-title":"Kidney Int"},{"issue":"5","key":"1770_CR17","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1067\/mlc.2002.128468","volume":"140","author":"DA Vesey","year":"2002","unstructured":"Vesey DA, Cheung C, Cuttle L, Endre Z, Gobe G, Johnson DW. Interleukin-1beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism. J Lab Clin Med. 2002;140(5):342\u201350.","journal-title":"J Lab Clin Med"},{"issue":"3","key":"1770_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/ki.1995.127","volume":"47","author":"G Lonnemann","year":"1995","unstructured":"Lonnemann G, Engler-Blum G, M\u00fcller GA, Koch KM, Dinarello CA. Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts. Kidney Int. 1995;47(3):845\u201354.","journal-title":"Kidney Int."},{"issue":"6","key":"1770_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1159\/000167656","volume":"8","author":"K Matsumoto","year":"1988","unstructured":"Matsumoto K, Dowling J, Atkins RC. Production of interleukin 1 in glomerular cell cultures from patients with rapidly progressive crescentic glomerulonephritis. Am J Nephrol. 1988;8(6):463\u201370.","journal-title":"Am J Nephrol"},{"issue":"3","key":"1770_CR20","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/ki.1993.98","volume":"43","author":"IL Noronha","year":"1993","unstructured":"Noronha IL, Kr\u00fcger C, Andrassy K, Ritz E, Waldherr R. In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int. 1993;43(3):682\u201392.","journal-title":"Kidney Int"},{"issue":"4","key":"1770_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/ki.1993.317","volume":"44","author":"K Yoshioka","year":"1993","unstructured":"Yoshioka K, Takemura T, Murakami K, Okada M, Yagi K, Miyazato H, Matsushima K, Maki S. In situ expression of cytokines in IgA nephritis. Kidney Int. 1993;44(4):825\u201333.","journal-title":"Kidney Int"},{"issue":"9","key":"1770_CR22","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.4049\/jimmunol.141.9.3050","volume":"141","author":"JM Boswell","year":"1988","unstructured":"Boswell JM, Yui MA, Burt DW, Kelley VE. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J Immunol. 1988;141(9):3050\u20134.","journal-title":"J Immunol."},{"issue":"4","key":"1770_CR23","first-page":"933","volume":"134","author":"K Matsumoto","year":"1989","unstructured":"Matsumoto K, Atkins RC. Glomerular cells and macrophages in the progression of experimental focal and segmental glomerulosclerosis. Am J Pathol. 1989;134(4):933\u201345.","journal-title":"Am J Pathol"},{"issue":"6","key":"1770_CR24","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/ndt\/12.6.1109","volume":"12","author":"GH Tesch","year":"1997","unstructured":"Tesch GH, Yang N, Yu H, Lan HY, Foti R, Chadban SJ, Atkins RC, Nikolic-Paterson DJ. Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney. Nephrol Dial Transplant. 1997;12(6):1109\u201315.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1770_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/ki.1993.70","volume":"43","author":"HY Lan","year":"1993","unstructured":"Lan HY, Nikolic-Paterson DJ, Zarama M, Vannice JL, Atkins RC. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int. 1993;43(2):479\u201385.","journal-title":"Kidney Int"},{"issue":"5","key":"1770_CR26","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ki.1995.185","volume":"47","author":"HY Lan","year":"1995","unstructured":"Lan HY, Nikolic-Paterson DJ, Mu W, Vannice JL, Atkins RC. Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. Kidney Int. 1995;47(5):1303\u20139.","journal-title":"Kidney Int"},{"issue":"5","key":"1770_CR27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0272-6386(97)90495-9","volume":"30","author":"A Chen","year":"1997","unstructured":"Chen A, Sheu LF, Chou WY, Tsai SC, Chang DM, Liang SC, Lin FG, Lee WH. Interleukin-1 receptor antagonist modulates the progression of a spontaneously occurring IgA nephropathy in mice. Am J Kidney Dis. 1997;30(5):693\u2013702.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"1770_CR28","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1093\/ndt\/gfp214","volume":"24","author":"LK Jones","year":"2009","unstructured":"Jones LK, O\u2019Sullivan KM, Semple T, Kuligowski MP, Fukami K, Ma FY, Nikolic-Paterson DJ, Holdsworth SR, Kitching AR. IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. Nephrol Dial Transplant. 2009;24(10):3024\u201332.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1770_CR29","doi-asserted-by":"publisher","first-page":"G1324","DOI":"10.1152\/ajpgi.90564.2008","volume":"296","author":"RG Gieling","year":"2009","unstructured":"Gieling RG, Wallace K, Han YP. Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol. 2009;296(6):G1324\u201331.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"1770_CR30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","volume":"139","author":"K Miura","year":"2010","unstructured":"Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, Olefsky JM, Brenner DA, Seki E. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology. 2010;139(1):323\u2013.","journal-title":"Gastroenterology"},{"issue":"10","key":"1770_CR31","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1172\/JCI60777","volume":"122","author":"J Petrasek","year":"2012","unstructured":"Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau M, Min SY, Kurt-Jones EA, Szabo G. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest. 2012;122(10):3476\u201389.","journal-title":"J Clin Invest."},{"issue":"7","key":"1770_CR32","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/j.1478-3231.2008.01775.x","volume":"28","author":"C Yan","year":"2008","unstructured":"Yan C, Zhou L, Han YP. Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure. Liver Int. 2008;28(7):959\u201371.","journal-title":"Liver Int."},{"issue":"4","key":"1770_CR33","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/hep.26429","volume":"58","author":"JP Pradere","year":"2013","unstructured":"Pradere JP, Kluwe J, De Minicis S, Jiao JJ, Gwak GY, Dapito DH, Jang MK, Guenther ND, Mederacke I, Friedman R, Dragomir AC, Aloman C, Schwabe RF. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology. 2013;58(4):1461\u201373.","journal-title":"Hepatology"},{"issue":"1","key":"1770_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF00197389","volume":"424","author":"R Mancini","year":"1994","unstructured":"Mancini R, Benedetti A, Jezequel AM. An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver. Virchows Arch. 1994;424(1):25\u201331.","journal-title":"Virchows Arch"},{"key":"1770_CR35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3389\/fimmu.2013.00351","volume":"4","author":"S Federici","year":"2013","unstructured":"Federici S, Martini A, Gattorno M. The central role of anti-IL-1 blockade in the treatment of monogenic and multi-factorial autoinflammatory diseases. Front Immunol. 2013;4:351.","journal-title":"Front Immunol."},{"issue":"1","key":"1770_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4161\/mabs.2.1.10328","volume":"2","author":"E Dhimolea","year":"2010","unstructured":"Dhimolea E. Canakinumab. MAbs. 2010;2(1):3\u201313.","journal-title":"MAbs."},{"key":"1770_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pupt.2015.01.005","volume":"31","author":"P Rogliani","year":"2015","unstructured":"Rogliani P, Calzetta L, Ora J, Matera MG. Canakinumab for the treatment of chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2015;31:15\u201327.","journal-title":"Pulm Pharmacol Ther"},{"key":"1770_CR38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fphar.2016.00467","volume":"7","author":"G Giancane","year":"2016","unstructured":"Giancane G, Minoia F, Dav\u00ec S, Bracciolini G, Consolaro A, Ravelli A. IL-1 inhibition in systemic juvenile idiopathic arthritis. Front Pharmacol. 2016;7:467.","journal-title":"Front Pharmacol."},{"issue":"12","key":"1770_CR39","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ, CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"3","key":"1770_CR40","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1186\/ar2438","volume":"10","author":"R Alten","year":"2008","unstructured":"Alten R, Gram H, Joosten LA, van den Berg WB, Sieper J, Wassenberg S, Burmester G, van Riel P, Diaz-Lorente M, Bruin GJ, Woodworth TG, Rordorf C, Batard Y, Wright AM, Jung T. The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis. Arthritis Res Ther. 2008;10(3):R67.","journal-title":"Arthritis Res Ther."},{"key":"1770_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cyto.2016.12.004","volume":"91","author":"ML Bonnemaison","year":"2017","unstructured":"Bonnemaison ML, Marks ES, Boesen EI. Interleukin-1\u03b2 as a driver of renal NGAL production. Cytokine. 2017;91:38\u201343.","journal-title":"Cytokine"},{"issue":"3","key":"1770_CR42","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1159\/000083414","volume":"99","author":"M Zhang","year":"2005","unstructured":"Zhang M, Tang J, Li X. Interleukin-1beta-induced transdifferentiation of renal proximal tubular cells is mediated by activation of JNK and p38 MAPK. Nephron Exp Nephrol. 2005;99(3):e68\u201376.","journal-title":"Nephron Exp Nephrol."},{"issue":"4","key":"1770_CR43","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/j.1523-1755.2004.00900.x","volume":"66","author":"LE Nee","year":"2004","unstructured":"Nee LE, McMorrow T, Campbell E, Slattery C, Ryan MP. TNF-alpha and IL-1beta-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells. Kidney Int. 2004;66(4):1376\u201386.","journal-title":"Kidney Int"},{"issue":"2","key":"1770_CR44","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1159\/000108645","volume":"107","author":"L Nee","year":"2007","unstructured":"Nee L, Tuite N, Ryan MP, McMorrow T. TNF-alpha and IL-1 beta-mediated regulation of MMP-9 and TIMP-1 in human glomerular mesangial cells. Nephron Exp Nephrol. 2007;107(2):e73\u201386.","journal-title":"Nephron Exp Nephrol."},{"issue":"9","key":"1770_CR45","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1096\/fj.06-7510com","volume":"21","author":"LY Leung","year":"2007","unstructured":"Leung LY, Tian D, Brangwynne CP, Weitz DA, Tschumperlin DJ. A new microrheometric approach reveals individual and cooperative roles for TGF-beta1 and IL-1\u03b2 eta in fibroblast-mediated stiffening of collagen gels. FASEB J. 2007;21(9):2064\u201373.","journal-title":"FASEB J."},{"issue":"1","key":"1770_CR46","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1046\/j.1523-1755.1998.00965.x","volume":"54","author":"IZ Pawluczyk","year":"1998","unstructured":"Pawluczyk IZ, Harris KP. Cytokine interactions promote synergistic fibronectin accumulation by mesangial cells. Kidney Int. 1998;54(1):62\u201370.","journal-title":"Kidney Int"},{"issue":"1","key":"1770_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 2011;75(1):50\u201383.","journal-title":"Microbiol Mol Biol Rev"},{"key":"1770_CR48","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12891-015-0602-6","volume":"16","author":"L Niccoli","year":"2015","unstructured":"Niccoli L, Cassar\u00e0 E, Kaloudi O, Nannini C, Romagnoli M, Cantini F. Systemic autoimmune disease in asbestosis rapidly responding to anti-interleukin-1beta antibody canakinumab: a case report. BMC Musculoskelet Disord. 2015;16:146.","journal-title":"BMC Musculoskelet Disord."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1770-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-1770-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1770-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T18:52:18Z","timestamp":1694544738000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-1770-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1770"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-1770-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"29 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"12"}}